Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


23.09.2019

1 Aliment Pharmacol Ther
1 Dig Dis Sci
1 J Gastroenterol
1 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. DAI C, Jiang M, Sun MJ
    Letter: increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFalpha agents, particularly etanercept, for autoimmune diseases other than IBD.
    Aliment Pharmacol Ther. 2019;50:834-835.
    PubMed     Text format    


    Dig Dis Sci

  2. GHOSH S, Bressler B, Petkau J, Thakkar RB, et al
    Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.
    Dig Dis Sci. 2019;64:1142-1149.
    PubMed     Text format     Abstract available


    J Gastroenterol

  3. NAGANUMA M, Sugimoto S, Fukuda T, Mitsuyama K, et al
    Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.
    J Gastroenterol. 2019 Sep 16. pii: 10.1007/s00535-019-01625.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  4. MALHAM M, Carlsen K, Riis L, Paerregaard A, et al
    Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis.
    Scand J Gastroenterol. 2019 Sep 17:1-6. doi: 10.1080/00365521.2019.1665097.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: